mNEXSPIKE® (COVID-19 vaccine, mRNA) – New drug approval
May 31, 2025 - Moderna announced the FDA approval of mNEXSPIKE (COVID-19 vaccine, mRNA), for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Download PDF
